NeuroOne (NMTC) Director Paul Buckman Receives Award

What Happened Paul Buckman, a director of NeuroOne Medical Technologies Corp (NMTC), received two awards on April 3, 2026: 41,929 restricted stock units (RSUs) and 26,036 derivative units/options. Both awards were granted at $0.00 (typical for equity grants) and will vest in equal monthly installments over a one‑year period.

Key Details

• Transaction date: 2026-04-03; Filing date (Form 4): 2026-04-07 (filing not marked as late in the report)
• Awards: 41,929 RSUs (grant) and 26,036 derivative units/options (grant)
• Price: $0.00 per share for both awards (no cash paid)
• Vesting: Both awards vest in 12 equal monthly installments over one year (F1 and F2)
• Shares owned after transaction: Not specified in the provided filing excerpt
• Transaction type codes: A = Award/Grant; derivative entry indicates an option or other equity derivative

Context

• These are grants (compensation/equity awards), not open‑market purchases or sales, so they do not by themselves signal buying or selling intent in the market.
• The derivative award is described as an option-like instrument that vests monthly; it does not indicate an immediate exercise or sale.